Skip to main content
David Moliterno, MD, Cardiology, Lexington, KY

David Jon Moliterno MD

Interventional Cardiology


Professor of Internal Medicine

Join to view full profile
  • 900 S. Limestone, 326A CTWLexington, KY 40536

  • Phone+1 859-218-0121

  • Fax+1 859-257-6060

Dr. Moliterno is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1993 - 1994
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1990 - 1993
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 1987 - 1990
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1987

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2004 - 2027
  • OH State Medical License
    OH State Medical License 1993 - 2012
  • TN State Medical License
    TN State Medical License 1988 - 1994
  • TX State Medical License
    TX State Medical License 1991 - 1994
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2013, 2015-2017
  • CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013, 2015-2017
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013, 2015-2017

Publications & Presentations

PubMed

Journal Articles

  • CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary Interventions  
    David J Moliterno, Susan S Smyth, Ahmed Abdel-Latif, JAMA
  • Effects of Genetic Variation in Protease Activated Receptor 4 After an Acute Coronary Syndrome: Analysis from the TRACER Trial  
    Paolo Fortina, David J Moliterno, Robert A Harrington, Kenneth W Mahaffey, ScienceDirect

Lectures

  • Best of JACC: Interventions 2018 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Best of JACC Journals and Eugene Braunwald Keynote 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Year in Review Speaker 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

  • CYP2C19 Genotyping to Guide Antiplatelet Therapy After Percutaneous Coronary InterventionsAugust 2020

Press Mentions

  • Veteran Interventional Cardiologist Named Editor-in-Chief of ACC Journal
    Veteran Interventional Cardiologist Named Editor-in-Chief of ACC JournalAugust 20th, 2026
  • Short DAPT Safe in ACS with No Ischemic Penalty: 4D-ACS
    Short DAPT Safe in ACS with No Ischemic Penalty: 4D-ACSMay 30th, 2025
  • Meta-Analysis Quashes Hopes for Routine Embolic Protection in TAVI
    Meta-Analysis Quashes Hopes for Routine Embolic Protection in TAVIMay 21st, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: